For many people, living with atrial fibrillation (AFib) can be challenging. It is a heart rhythm disorder that affects millions of people worldwide. Patients with this condition are at an increased risk of developing complications such as blood clots, stroke, and heart failure. However, with the latest medical advancements, many effective treatments have emerged, and one of them is Watchman Surgery.
Watchman Surgery is an innovative, minimally-invasive procedure that is designed to reduce the risk of blood clots, stroke, and other complications associated with AFib. In this article, we will discuss what Watchman Surgery is, how it works, and who is eligible for it.
What is Watchman Surgery?
Watchman Surgery, also known as Watchman Procedure or Left Atrial Appendage Closure (LAAC), is a one-time surgical procedure that involves implanting a small, cage-like device (Watchman Device) in the heart. The device has a soft, flexible covering that seals off the Left Atrial Appendage (LAA) – a small pouch in the heart’s left atrium – where clots commonly form in patients with AFib.
The Watchman Device is typically made of bioabsorbable material and comes in different sizes. Once inserted, the device stays permanently in the heart and is integrated into the heart’s tissue over time.
How does Watchman Surgery work?
The Watchman Surgery procedure involves a few simple steps and usually takes about an hour to complete. During the surgery, patients are under general anesthesia, and a small incision is made in the groin area to access the femoral vein. The Watchman Device is then inserted through a small tube called a catheter and threaded into the heart, where it is placed in the LAA.
Once in place, the device expands, and the soft, flexible covering self-expands to fill up the LAA. This seals off the area, preventing blood clots from forming and reducing the risks of stroke and other complications associated with AFib.
Who is eligible for Watchman Surgery?
Watchman Surgery is usually recommended for patients with AFib who are at an increased risk of developing blood clots or stroke and cannot take blood-thinning medication due to various reasons like allergies. Doctors determine eligibility for the procedure using factors such as age, medical history, and risk factors involved.
It’s important to note that Watchman Surgery is not suitable for everyone, as there are potential risks and complications associated with the procedure. Therefore, patients should work closely with their healthcare providers to determine if the treatment option is right for them.
Conclusion:
In conclusion, Watchman Surgery is an innovative, minimally-invasive procedure that offers a new treatment option for patients with AFib who cannot take blood-thinning medication and are looking to reduce their risk of stroke and other complications. The procedure is safe and effective and has been shown to significantly reduce the risks of AFib-related complications in eligible patients. If you are living with AFib and considering Watchman Surgery as a treatment option, be sure to speak with your healthcare provider to determine if it’s the right fit for you.